Gingival Recession and Localized Aggressive Periodontitis Among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy

被引:6
|
作者
Blignaut, Elaine [1 ]
Rossouw, Theresa M. [2 ]
Becker, Piet J. [3 ]
Mavuso, Diana S. [1 ]
Feucht, Ute D. [4 ]
机构
[1] Univ Pretoria, Sch Dent, Dept Oral Pathol & Oral Biol, Pretoria, South Africa
[2] Univ Pretoria, Sch Med, Dept Immunol, Pretoria, South Africa
[3] Univ Pretoria, Res Support Off, Pretoria, South Africa
[4] Univ Pretoria, Sch Med, Fac Hlth Sci, Dept Paediat, Pretoria, South Africa
关键词
HIV infection; children; adolescents; aggressive periodontitis; South Africa;
D O I
10.1097/INF.0000000000002166
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Limited information is available on gingival recession or localized aggressive periodontitis among HIV-infected children and adolescents. This study reports on the prevalence of these conditions among children and adolescents receiving antiretroviral therapy (ART). Methods: A cross-sectional study on HIV-infected children and adolescents attending a Pediatric HIV clinic in Gauteng, South Africa, between January 2013 and June 2016. Patients received an oral examination and oral hygiene instructions, irrespective of oral- or dental-related complaints. Hard and soft tissue pathology was managed and recorded, together with relevant demographic and clinical data. Statistical analysis was performed in Stata 14 with P < 0.05 as significant. Results: A total of 554 children and adolescents 5-19 years of age (median age: 12.2 years; interquartile range: 10.3-14.9) were included, of whom 78 (14.1%) presented with gingival recession on permanent mandibular incisors and/or localized aggressive periodontitis of molar teeth. Multivariable logistic regression revealed that patients with gingival recession and aggressive periodontitis had a significantly shorter duration of ART and were more likely to have suboptimal HIV control (CD4 count <= 500 cells/mu L and/or HIV viral load >= 50 copies/mL) and be on advanced ART regimens after virologic failure on first- and second-line treatment. Conclusions: The results emphasize the importance of oral health care among HIV-infected children and adolescents from the onset, to prevent and manage conditions that could result in tooth loss and permanent disfigurement. This is of particular importance in the presence of virologic failure and immunosuppression.
引用
收藏
页码:E112 / E115
页数:4
相关论文
共 50 条
  • [1] DYSLIPIDEMIAS IN HIV-INFECTED CHILDREN AND ADOLESCENTS RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
    Mancao, M.
    Abesamis, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 380 - 380
  • [2] Guideline for Antiretroviral Therapy of HIV-Infected Children and Adolescents
    Neubert, J.
    Niehues, T.
    Baumann, U.
    Buchholz, B.
    Notheiss, G.
    Wintergerst, U.
    Blume, J.
    Feiterna-Sperling, C.
    Laws, H. -J
    Linde, R.
    Koenigs, C.
    KLINISCHE PADIATRIE, 2012, 224 (02): : 98 - 110
  • [3] Hepatotoxicity in HIV-infected children and adolescents on antiretroviral therapy
    Mantes Gil, Am Cecilia
    Lorenzetti, Raquel
    Mendes, Gun Bergsten
    Morcillo, Andre Moreno
    Dalbo Contreras Toro, Adyleia Aparecida
    Nolasco do Silva, Marcos Tadeu
    dos Santos Vilela, Maria Marluce
    SAO PAULO MEDICAL JOURNAL, 2007, 125 (04): : 205 - 209
  • [4] Safety and Tolerability of Antiretroviral Therapy Among HIV-Infected Children And Adolescents In UGANDA
    Tukei, Vincent J.
    Asiimwe, Alice
    Maganda, Albert
    Atugonza, Rita
    Sebuliba, Isaac
    Bakeera-Kitaka, Sabrina
    Musoke, Phillipa
    Kalyesubula, Israel
    Kekitiinwa, Adeodata
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 (03) : 274 - 280
  • [5] Mitochondrial dysfunction in HIV-infected children receiving or not antiretroviral therapy
    Moren, C.
    Garrabou, G.
    Noguera, A.
    Nicolas, M.
    Cardellach, F.
    Fortuny, C.
    Miro, O.
    ANTIVIRAL THERAPY, 2008, 13 (08) : A82 - A82
  • [6] Predictors of mortality among HIV-infected children receiving highly active antiretroviral therapy
    Nlend, A. E. Njom
    Loussikila, A. B.
    MEDECINE ET MALADIES INFECTIEUSES, 2017, 47 (01): : 32 - 37
  • [7] Seroprevalence of Hepatitis B Among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy in the TREAT Asia Pediatric HIV Observational Database
    Aurpibul, Linda
    Kariminia, Azar
    Vibol, Ung
    Fong, Moy Siew
    Oanh Ngoc Le
    Hansudewechakul, Rawiwan
    Bunupuradah, Torsak
    Kurniati, Nia
    Chokephaibulkit, Kulkanya
    Kumarasamy, Nagalingeswaran
    Wati, Dewi Kumara
    Yusoff, Nik Khairulddin Nik
    Razali, Kamarul Azahar Mohd
    Nallusamy, Revathy A.
    Sohn, Annette H.
    Lumbiganon, Pagakrong
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (08) : 788 - 793
  • [8] Antiretroviral therapy in HIV-infected children
    Fan, Conghai
    Zhang, Fengchao
    Chen, Chao
    MINERVA PEDIATRICA, 2019, 71 (05) : 455 - 460
  • [9] Growth among HIV-infected Children Receiving Antiretroviral Therapy in Dar es Salaam, Tanzania
    Mwiru, Ramadhani S.
    Spiegelman, Donna
    Duggan, Christopher
    Seage, George R., III
    Semu, Helen
    Chalamilla, Guerino
    Kisenge, Rodrick
    Fawzi, Wafaie W.
    JOURNAL OF TROPICAL PEDIATRICS, 2014, 60 (03) : 179 - 188
  • [10] Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy
    Puthanakit, Thanyawee
    Aurpibul, Linda
    Oberdorfer, Peninnah
    Akarathum, Noppadon
    Kanjananit, Suparat
    Wannarit, Pornphun
    Sirisanthana, Thira
    Sirisanthana, Virat
    CLINICAL INFECTIOUS DISEASES, 2007, 44 (04) : 599 - 604